Contractor was able to provide process research support and cGMP manufacturing to develop the synthesis of a novel oncology compound that enabled the client to out-license the compound to a licensor with downstream potential revenues upwards of 1 billion dollars.
Consultant was able to identify a very low cost and strategic source in India for an advanced intermediate supporting the synthesis for an API in Phase 2 for a virtual pharmaceutical company. Final API was out-license to a major pharmaceutical company and potential downstream revenues to exceed one billion dollars in potential revenues.
Assisted a virtual pharmaceutical company in identifying the most stable and soluble salt form of an API salt so for an IND filing.
Consultant was able to provide consulting service to the small virtual biotechnology company to assist in moving a compound from Phase 2 to commercial readiness.